期刊文献+

中重度眼睑痉挛的临床特征及治疗体会 被引量:10

Clinical characteristics and treatment of moderately severe blepharospasm
原文传递
导出
摘要 目的探讨中重度眼睑痉挛患者的临床特征及治疗效果。方法取病例为2009年1月至2010年12月在眼科门诊就诊的中重度眼睑痉挛患者34例,其临床资料包括眼部症状、泪河高度、基础泪液分泌实验(Schiemer Itest,SIt)、泪膜破裂时间(break—uptime,BUT)、角膜荧光素染色(fluorescent,F1)。治疗方法选择A型肉毒毒素眼周注射联合人T泪液治疗,必要时加行泪点栓塞术,观察治疗效果并随访1年。结果34例中20例中度(Ⅲ级)痉挛,14例为重度(Ⅳ级)痉挛,所有患者均主诉不自主频繁眨眼或眼周皮肤跳动,同时伴发眼十涩感、视疲劳、眼痒及视物模糊等症状。相关检查,泪河高度均小于0.3mm,SIt≤5mm者26例,5mm〈SIt≤10mm者8例;BUT≤5S者32例,5s〈BUT≤10S者2例;FI染色评分为7.1±2.8;治疗后完全缓解者19例(55.9%),明显缓解15例(44.1%),有效率100%;29.4%患者痉挛缓解维持时间4-6个月,32.4%为6-8个月,大于8个月者为38.2%。结论大部分中重度眼睑痉挛合并有干眼,采用眼周皮下注射A型肉毒毒素,并坚持人T泪漓治疗.一诉兽时行汨点栓寨术对眼呤瘩奎合并干眼不失为一条筒堕可行的有效方浃。 Objective To explore clinical characteristics and treatment of moderately severe blepharospasm. Methods Thirty-four patients with moderate to severe blepharospasm were recruited from our outpatient clinic from January 2009 to December 2010 as case group. The following items were recorded in these patients, including symptoms, slit-lamp examination, tear-up time, basal Schiemer test, fluorescent staining. These patients were treated with Botulinum toxin A injection com- bined with artificial tears, and lacrimal plug was applied in some severe patients, therapeutic effect were observed and post-treatment follow-up visits were performed. Results In 34 patients, 20patients were moderate blepharospasm, while 14 were severe. All patients complained frequently involuntary blinks, and also complained about sensation of dryness, asthenopia, itching and blurred vision. Slit-lamp examination showed all patients' lacrimal river under 0.3mm, 26 cases' Schiemer I test equal or lower than 5mm, 8 cases were between 5 and 10mm. BUT of 32 cases were equal or low- er than 5s, while 2 cases were between 5 and 10s. The score of fluorescent staining were 7.1±2.8. After treatment, there was 55.9% cases complete remission, 44.1% cases partial remission, efficiency rate was 100%. The duration of remission between 4-6 months were 29.4% cases, between 6-8 months were 32.4%, higher than 8 months were 38.2%. Conclusions Many patients with moderate to severe blepharospasm also suffer from dry eye. Botulinum toxin A injection combined with artifi- cial tears, lacrimal plug as needed, is simple and effective in relieving blepharospasm and successful in treating dry eye syndrome.
出处 《中国实用眼科杂志》 CSCD 北大核心 2012年第6期742-744,共3页 Chinese Journal of Practical Ophthalmology
基金 福建医科大学教授学术发展基金(js09009) 福建省创新平台基金项目(2010Y2003)
关键词 眼睑痉挛 干眼 A型肉毒毒素 Blepharospasm Dry eye Botulinum toxin A
  • 相关文献

参考文献10

  • 1Hallett M.Blepharospasm: recent advances [J ].Neurology, 2002,59: 1306-1312.
  • 2Price J,O'Day, J.A comparative study of lear secretion in blepharospasm and hemifacial spasm patients treated with boutlinum toin[J].J Clin Neuroophthalmol. 1993, 13 : 67-71.
  • 3汪晓楠,万新华,王琳,杨英麦.良性特发性眼睑痉挛的发病危险因素分析[J].中华神经科杂志,2011,44(6):395-399. 被引量:18
  • 4Cohen DA,Savinop,Stern Mll,et al.Botulinum injection therapy, for blephrospasm:a review and report of 7.5 patient[J].Clin Neuropharmacol, 1986,9 : 415.
  • 5张梅,陈家祺,刘祖国,罗丽辉,肖启国,姚勇,陈龙,张志红.干眼患者115例的临床特点分析[J].中华眼科杂志,2003,39(1):5-9. 被引量:118
  • 6Kim JC. Chun JS, thing R.RS,et al. Delayed tear clearanee induced by botulinam torin injection in essential blepharospasm and hemifaeial spasm[J]. J Korean Ophthalmol Soc. 1995.36: 1084-1092.
  • 7Evinger C, Bao JP,, Powers AS. et al.Dry eye, blinking, and blepharospasm[ J ].Mov Disord. 2002.17 Suppl 2 : s75-78.
  • 8罗正容,康前雁,周芳.A型肉毒毒素治疗眼睑、面肌痉挛的临床研究[J].中华眼科杂志,2001,37(3):227-227. 被引量:20
  • 9Horwath-Winter, BergloetT, Floegel,et al.Botulinum toxin A treatment in patients suffering from blepharospasm and dry [J]. Br J Ophthalmol,2003,87:54-56.
  • 10杨代慧,张晓俊,柯秀峰,等.人工泪液联合泪点栓寨术治疗眼干燥症的效果观察[J].眼外伤职眼病杂志.2006,28(12):933-936.

二级参考文献26

  • 1戴壮,卢炜.A型肉毒杆菌毒素治疗眼睑及面肌痉挛的临床研究[J].中华眼科杂志,1993,29(3):144-145. 被引量:54
  • 2胡兴越,程源深,耿昱,王谨.A型肉毒杆菌毒素治疗头颈部肌张力不全的临床研究[J].临床神经病学杂志,1996,9(5):281-283. 被引量:11
  • 3Hallett M,Evinger C,Jankovic J,et al.Update on blepharospasm:report from the BEBRF International Workshop.Neurology,2008,71:1275-1282.
  • 4Hallett M.Blepharospasm:recent advances.Neurology,2002,59:1306-1312.
  • 5Fahn S,Bressman SB,Marsden CD.Classification of dystonia//Fahn S,Marsden CD,DeLong MR.Dystonia 3,Advanced Neurology.Vol 78.Philadelphia:Lippencott-Raven,1998:1-10.
  • 6Boyer P.Do anxiety and depression have a common pathophysiological mechanism? Acta Psychiatr Scand Suppl,2000,406:24-29.
  • 7Heim C,Ehlert U,Hellhammer DH.The potential role of hypocortisolism in the pathophysiology of stress-related bodily disorders.Psychoneuroendocrinology,2000,25:1-35.
  • 8Pruessner JC,Champagne F,Meaney MJ,et al.Dopamine release in response to a psychological stress in humans and its relationship to early life maternal care:a positron emission tomography study using "C raclopride.J Neurosci,2004,24:2825-2831.
  • 9Schicatano EJ,Basso MA,Evinger C.Animal model explains the origins of the cranial dystonia benign essential blepharospasm.J Neurophysiol,1997,77:2842-2846.
  • 10Peshori KR,Schicatano EJ,Gopalaswamy R,et al.Aging of the trigeminal blink system.Exp Brain Res,2001,136:351-363.

共引文献152

同被引文献76

引证文献10

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部